Back to mobile site

Flexion Therapeutics (FLXN) PT Lowered to $16 at Oppenheimer

January 14, 2021 5:50 AM EST
Get Alerts FLXN Hot Sheet
Price: $24.95 -0.08%

Rating Summary:
    11 Buy, 7 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer analyst Francois Brisebois lowered the price target on Flexion Therapeutics (NASDAQ: FLXN) to $16.00 (from $19.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change